Akşit, ErcanKoder, Ahmet2024-01-222024-01-222023Akşit E, Köder A. (2023) Is There a Relationship Between Olfactory Dysfunction and Decreased Thromboembolic Events After the First Wave of the COVID-19 Pandemic?. Balkan Medical Journal, 40(3), 228. doi: 10.4274/balkanmedj.galenos.2023.2023-3-152146-31232146-3131https://doi.org/10.4274/balkanmedj.galenos.2023.2023-3-15https://hdl.handle.net/20.500.12428/5265To the Editor, The Coronavirus disease-2019 (COVID-19) has caused a global pandemic.1 A recent study suggested that the prevalence of cardiomyocyte injury and microvascular thrombogenicity was lower in the second wave of the COVID-19 pandemic compared with the first wave.2 The importance of agents such as ticagrelor for reducing thromboembolic events in COVID-19 has also been noted.3 A recent study suggested that the UGT2A1/UGT2A2 genes are responsible for the olfactory dysfunction (OD) attributed to COVID-19.4 Interestingly, UGT2A1 polymorphisms are known to be associated with platelet reactivity.5eninfo:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivs 3.0 United StatesCOVID-19Humans Olfaction DisordersEtiologyPandemicsIs There a Relationship Between Olfactory Dysfunction and Decreased Thromboembolic Events After the First Wave of the COVID-19 Pandemic?Letter40322810.4274/balkanmedj.galenos.2023.2023-3-15Q2WOS:0009934602000142-s2.0-85159731573125568136959697